| Original language | English |
|---|---|
| Pages (from-to) | 1605-1608 |
| Number of pages | 4 |
| Journal | European Child and Adolescent Psychiatry |
| Volume | 33 |
| Issue number | 5 |
| Early online date | 25 Apr 2024 |
| DOIs | |
| Publication status | Published - May 2024 |
ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines
Samuele Cortese*, David Coghill, Joerg M. Fegert, Gregory W. Mattingly, Luis A. Rohde, Ian C.K. Wong, Stephen V. Faraone
*Corresponding author for this work
- University of Southampton
- University of Southampton, Faculty of Medicine
- Solent NHS Trust
- Hassenfeld Children’s Hospital
- Università degli Studi di Bari
- University of Melbourne
- Murdoch Children's Research Institute
- University Hospital Ulm
- Feinstein Institute for Medical Research
- Washington University in St. Louis
- Hospital de Clinicas de Porto Alegre
- Medical Council
- National Institute of Developmental Psychiatry
- Norton College of Medicine
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)